date,title,source
Nov-14-18,Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update,GlobeNewswire
Nov-15-18,Diffusion Pharmaceuticals Chief Scientific Officer Dr. John L. Gainer to Present at 2018 Annual Meeting of the Society for NeuroOncology,GlobeNewswire
Dec-10-18,DFFN: Phase 2 Clinical Trial of TSC in Acute Stroke to Commence in 2019,Zacks Small Cap Research
Dec-13-18,Diffusion Pharmaceuticals Announces 1-for-15 Reverse Stock Split As Part Of NASDAQ Compliance Plan,GlobeNewswire
Dec-17-18,4 Stocks Providing Investor Opportunity Right Now,ACCESSWIRE
Dec-17-18,U.S. Patent Office Awards Diffusion Exclusive Rights for Use of TSC in Conjunction with Only FDA-Approved Stroke Therapeutic,GlobeNewswire
Dec-18-18,Today's Research Reports on Trending Tickers: Evofem Biosciences and Diffusion Pharmaceuticals,ACCESSWIRE
Jan-03-19,Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market,GlobeNewswire
Jan-04-19,Diffusion Pharmaceuticals Chief Executive Officer David Kalergis to Present at 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-22-19,How Does Investing In Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Impact The Volatility Of Your Portfolio?,Simply Wall St.
Feb-11-19,Poster Presented at International Stroke Conference Describing Diffusions On-Ambulance Phase 2 Trial with TSC for Treating Acute Stroke,GlobeNewswire
Mar-08-19,4 Stocks Join Ben Graham Net-Net Screener Friday,GuruFocus.com
Mar-20-19,Diffusion Pharmaceuticals Reports 2018 Financial Results and Provides Business Update,GlobeNewswire
Apr-17-19,DFFN: Data from Initial 8 Patients in Phase 3 GBM Trial Expected in mid-2019,Zacks Small Cap Research
May-09-19,Diffusion Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update,GlobeNewswire
May-13-19,DFFN: Phase 2 Study of TSC in Stroke to Start in Summer 2019,Zacks Small Cap Research
May-23-19,Diffusion Pharmaceuticals Receives Notice of Intention to Grant a Patent Related to Use of TSC in Combination with tPA in Ischemic Stroke from European Patent Office,GlobeNewswire
May-24-19,Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement,GlobeNewswire
May-28-19,Diffusion Pharmaceuticals Inc. Announces Closing of $6.45 Million Offering Priced At-the-Market,GlobeNewswire
